Carcinogenesis and Ito cell

癌变与伊藤细胞

基本信息

  • 批准号:
    08670598
  • 负责人:
  • 金额:
    $ 1.41万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

Administration of a choline deficient L-amino acid defined (CDAA) diet for 16 weeks led to the development of preneoplastic lesions that were positive for the placental form of glutathione S-transferase (GSTP) and induced hepatocellular carcinoma in 90% of rats after one year. Prolyl 4-hydroxylase inhibitor (HOE 077, 200 ppm) significantly reduced the size and incidence of preneoplastic lesions after 16 weeks and also the incidence of HCC (50%) in rats fed a CDAA diet for one year by the inactivation of Ito cell resulting in the prevention of fibrosis.Injection of pig serum into rats twice a week for 8 weeks induced.TGF-beta_1 mRNA expression and protein production resulting in liver fibrosis without parenchymal cell injury. Administration of a choline deficient L-amino acid defined (CDAA) diet for 6 weeks with or without pig serum pretreatment led to the development of preneoplastic lesions that were positive for the placental form of glutathione S- transferase (GSTP). Pig serum pretreatment induced more activated stellate cells with increased TGF-beta_1, mRNA expression and protein production in the livers of rats subsequently fed a CDAA diet for 6 weeks compared to rats fed the CDAA diet alone.These results indicate that pre-existing fibrosis with the activated stellate cells accelerates the development of preneoplastic lesions in a CDAA.diet model and that TGF-beta_1 induced by pig serum treatment failed to prevent the development of preneoplastic lesions in a CDAA-diet model.Cancer cell seems to prevent the activation of Ito cell in co-culture system but further examinations are necessary.
以胆碱缺乏的L氨基酸饲料喂养大鼠16周,可引起胎盘型谷胱甘肽S转移酶阳性的癌前病变,1年后90%的大鼠发生肝细胞癌。Prolyl 4-羟基酶抑制剂(HOE 077,200ppm)可通过使Ito细胞失活,预防肝纤维化,显著减少16周后癌前病变的大小和发生率,并降低肝细胞癌(50%)的发生率。大鼠每周两次注射猪血清,连续8周,转化生长因子-β1mRNA和蛋白的表达和蛋白产生导致肝纤维化,而实质细胞没有损伤。给予胆碱缺乏的L氨基酸限定饮食6周,并加或不加猪血清预处理,可导致胎盘型谷胱甘肽S转移酶阳性的癌前病变的发生。与单纯饲喂CDAA饲料的大鼠相比,猪血清预处理诱导了更多的活化星状细胞,并增加了肝组织中转化生长因子-β1的表达和蛋白产量。这些结果表明,在CDAA饮食模型中,活化的星状细胞预先存在的纤维化加速了癌前病变的发展,而猪血清处理诱导的转化生长因子-β1在CDAA饮食模型中未能阻止癌前病变的发展。在共培养系统中,癌细胞似乎阻止了Ito细胞的激活,但需要进一步的检查。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sakaida I.: "Fibrosis accelerates the development of enzyme-altered lesions in the rat liver." Hepatology. 28. 1247-1252 (1998)
Sakaida I.:“纤维化加速了大鼠肝脏酶改变病变的发展。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isao Sakaida: "Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet." Journal of Hepatology. 28. 298-306 (1998)
Isao Sakaida:“草药 Sho-saiko-to (TJ-9) 可预防由缺乏胆碱的 L-氨基酸饮食引起的大鼠肝硬化的肝纤维化和酶改变病变。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isao Sakaida: "The prolyl4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells,reducing procollagen geneexpression in rat liver fibrosis induced by choline deficient L-amino acid-defined diet." Hepatology. 23. 755-763 (1996)
Isao Sakaida:“脯氨酰 4-羟化酶抑制剂 HOE 077 可防止 Ito 细胞活化,减少由缺乏胆碱的 L-氨基酸饮食诱导的大鼠肝纤维化中的前胶原基因表达。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isao Sakaida: "Carcinogenesis and fibrosis" Bull.Yamaguchi Med.Sch.(in press).
Isao Sakaida:“癌变和纤维化”Bull.Yamaguchi Med.Sch.(印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sakaida I: "The iron chelator deferoxamine reduces preneoplastic lesions In the liver induced by a choline-deficient L-amino acid defined dietin the rat." Digestive Disease and Science. 発表予定.
Sakaida I:“铁螯合剂去铁胺可减少大鼠因缺乏胆碱的 L-氨基酸饮食引起的肝脏肿瘤前病变。” 计划发表。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAKAIDA Isao其他文献

SAKAIDA Isao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAKAIDA Isao', 18)}}的其他基金

The development research of liver regeneration therapy used bone marrow drived liver repaired cell
骨髓驱动肝修复细胞肝再生治疗的进展研究
  • 批准号:
    20H03663
  • 财政年份:
    2020
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of liver regeneration therapy with higher therapeutic effects on liver cirrhosis using a middle-large size liver cirrhosis model.
利用中大型肝硬化模型开发对肝硬化具有更高治疗效果的肝再生疗法。
  • 批准号:
    17H04162
  • 财政年份:
    2017
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of new gene transfer system for small fish
小型鱼类新基因转移系统的开发
  • 批准号:
    22659148
  • 财政年份:
    2010
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanism of fibrolysis and effect on cancer by autologus bone marrow cell infusion therapy for liver cirrhosis
自体骨髓细胞输注治疗肝硬化的纤维化机制及抗癌作用
  • 批准号:
    19390199
  • 财政年份:
    2007
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The development of cell therapy for liver fibrolysis and prevention of carcinogenesis using bone marrow cell transplantaion
利用骨髓细胞移植治疗肝纤维化和预防癌变的细胞疗法的发展
  • 批准号:
    16590597
  • 财政年份:
    2004
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cross-talk of Ito(stellate) cell and preneoplastic and cancer cells of hepatocarcinogenesis
伊藤星状细胞与肝癌癌前及癌细胞的串扰
  • 批准号:
    11670507
  • 财政年份:
    1999
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 批准年份:
    2016
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目

相似海外基金

Characterizing Rouge Macrophages in Lung Fibrosis and Cancer: Uncovering Common Biomarkers and Therapeutic Targets to Halt Disease Progression
表征肺纤维化和癌症中的胭脂巨噬细胞:发现常见的生物标志物和阻止疾病进展的治疗靶点
  • 批准号:
    486870
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Miscellaneous Programs
Targeting fibrosis to change cancer outcomes
针对纤维化改变癌症结果
  • 批准号:
    10748730
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Radiation-Induced Fibrosis and Co-occurring Adverse Treatment-Related Effects in Head and Neck Cancer Survivors
头颈癌幸存者中放射诱发的纤维化和同时发生的不良治疗相关影响
  • 批准号:
    10734092
  • 财政年份:
    2023
  • 资助金额:
    $ 1.41万
  • 项目类别:
Development of pancreatic cancer treatment using fibrosis-inhibiting peptide and anticancer drug-encapsulating liposome
使用纤维化抑制肽和抗癌药物封装脂质体治疗胰腺癌的进展
  • 批准号:
    22K07971
  • 财政年份:
    2022
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fibrotic remodeling of lymph nodes disrupts T cell function in fibrosis and cancer
淋巴结纤维化重塑破坏纤维化和癌症中的 T 细胞功能
  • 批准号:
    10470223
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Connective Tissue Growth Factor (CTGF): A key player in Fibrosis and Cancer
结缔组织生长因子 (CTGF):纤维化和癌症的关键参与者
  • 批准号:
    443371
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Operating Grants
Macrophage phenotyping in lung fibrosis and cancer: Identification of shared markers and therapeutic targets to prevent progression of disease
肺纤维化和癌症中的巨噬细胞表型:鉴定共享标记物和治疗靶点以预防疾病进展
  • 批准号:
    458584
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Studentship Programs
Development of a cancer fibrosis inhibition immunotherapy in breast cancer using Hedgehog signaling inhibitor
使用 Hedgehog 信号抑制剂开发乳腺癌癌症纤维化抑制免疫疗法
  • 批准号:
    21K08673
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fibrotic remodeling of lymph nodes disrupts T cell function in fibrosis and cancer
淋巴结纤维化重塑破坏纤维化和癌症中的 T 细胞功能
  • 批准号:
    10305424
  • 财政年份:
    2021
  • 资助金额:
    $ 1.41万
  • 项目类别:
Analysis of fibrosis of cancer stroma in the hepatobiliary and pancreatic tumors.
肝胆胰肿瘤癌基质纤维化分析。
  • 批准号:
    20K08996
  • 财政年份:
    2020
  • 资助金额:
    $ 1.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了